000 01416 a2200409 4500
005 20250514064453.0
264 0 _c20030508
008 200305s 0 0 eng d
022 _a0091-6749
024 7 _a10.1067/mai.2003.1391
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMeyer, Katie A
245 0 0 _aResponse to montelukast among subgroups of children aged 2 to 14 years with asthma.
_h[electronic resource]
260 _bThe Journal of allergy and clinical immunology
_cApr 2003
300 _a757-62 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAcetates
_xtherapeutic use
650 0 4 _aAdolescent
650 0 4 _aAsthma
_xdrug therapy
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aCyclopropanes
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aForced Expiratory Volume
_xdrug effects
650 0 4 _aHumans
650 0 4 _aLeukotriene Antagonists
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aQuinolines
_xtherapeutic use
650 0 4 _aSulfides
700 1 _aArduino, Jean Marie
700 1 _aSantanello, Nancy C
700 1 _aKnorr, Barbara A
700 1 _aBisgaard, Hans
773 0 _tThe Journal of allergy and clinical immunology
_gvol. 111
_gno. 4
_gp. 757-62
856 4 0 _uhttps://doi.org/10.1067/mai.2003.1391
_zAvailable from publisher's website
999 _c12495850
_d12495850